NO934897D0 - Fremgangsmaate for fremstilling av et farmasoeytisk preparat - Google Patents
Fremgangsmaate for fremstilling av et farmasoeytisk preparatInfo
- Publication number
- NO934897D0 NO934897D0 NO934897A NO934897A NO934897D0 NO 934897 D0 NO934897 D0 NO 934897D0 NO 934897 A NO934897 A NO 934897A NO 934897 A NO934897 A NO 934897A NO 934897 D0 NO934897 D0 NO 934897D0
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- procedure
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B25/00—Multi-stage pumps
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- AIDS & HIV (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Mechanical Engineering (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89827386A | 1986-08-20 | 1986-08-20 | |
US4502687A | 1987-05-01 | 1987-05-01 | |
US6799687A | 1987-06-29 | 1987-06-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO934897D0 true NO934897D0 (no) | 1993-12-29 |
NO934897L NO934897L (no) | 1993-12-29 |
NO302176B1 NO302176B1 (no) | 1998-02-02 |
Family
ID=27366600
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO873495A NO300462B1 (no) | 1986-08-20 | 1987-08-19 | Monoklonale antistoffer og peptider som kan anvendes til diagnose av HIV-infeksjoner |
NO934897A NO302176B1 (no) | 1986-08-20 | 1993-12-29 | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO873495A NO300462B1 (no) | 1986-08-20 | 1987-08-19 | Monoklonale antistoffer og peptider som kan anvendes til diagnose av HIV-infeksjoner |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS6485928A (no) |
KR (1) | KR920008744B1 (no) |
AT (1) | AT398080B (no) |
AU (1) | AU616156B2 (no) |
BE (1) | BE1000811A4 (no) |
CH (1) | CH675728A5 (no) |
CS (1) | CS275838B6 (no) |
DE (1) | DE3727703A1 (no) |
DK (1) | DK433087A (no) |
ES (1) | ES2010727A6 (no) |
FI (1) | FI873553A (no) |
FR (1) | FR2603107B1 (no) |
GB (1) | GB2196634B (no) |
GR (1) | GR871298B (no) |
HU (1) | HU214439B (no) |
IE (1) | IE60671B1 (no) |
IL (1) | IL83580A (no) |
IT (1) | IT1222518B (no) |
LU (1) | LU86972A1 (no) |
NL (1) | NL8701950A (no) |
NO (2) | NO300462B1 (no) |
NZ (1) | NZ221440A (no) |
OA (1) | OA08652A (no) |
PL (1) | PL155084B1 (no) |
PT (1) | PT85567B (no) |
SE (1) | SE506025C2 (no) |
YU (1) | YU152587A (no) |
ZW (1) | ZW15487A1 (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP96A (en) * | 1986-06-03 | 1990-08-12 | The Usa Dept Of Commerce | Small peptides which inhibit binding to T-4 receptors and act as immunogens. |
AU625720B2 (en) * | 1987-05-01 | 1992-07-16 | Genetic Systems Corporation | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
US5981278A (en) * | 1987-05-29 | 1999-11-09 | Tanox, Inc. | Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS |
US6657050B1 (en) | 1987-05-29 | 2003-12-02 | Tanox, Inc. | Chimeric viral-neutralizing immunoglobulins |
US5834599A (en) * | 1987-05-29 | 1998-11-10 | Tanox Biosystems, Inc. | Immunoconjugates which neutralize HIV-1 infection |
CA1339857C (en) * | 1987-05-29 | 1998-05-05 | Cecily Rou-Yun Sun | Monoclonal antibodies to gp120 which neutraleze hiv-1 |
JP2569185B2 (ja) * | 1988-01-26 | 1997-01-08 | アメリカ合衆国 | 抗hiv応答を喚起する合成抗原 |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
IL90048A0 (en) * | 1988-04-25 | 1989-12-15 | Merck & Co Inc | Recombinant gag precursor of hiv,its preparation and its use as aids vaccine |
US5562905A (en) * | 1988-04-26 | 1996-10-08 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
EP0339504A3 (en) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
FR2632310B1 (fr) * | 1988-06-06 | 1992-04-10 | Pasteur Institut | Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles |
JPH04502760A (ja) * | 1988-10-03 | 1992-05-21 | レプリゲン・コーポレーション | エイズの診断,予防および治療に有効な新規hiv蛋白質およびペプチド |
CA2025481A1 (en) * | 1989-09-19 | 1991-03-20 | Peter J. Kniskern | Vaccine for aids and hepatitis b |
SE9000333D0 (sv) * | 1990-01-31 | 1990-01-31 | Britta Wahren | Monoklonal antikropp |
SE468168B (sv) * | 1990-02-20 | 1992-11-16 | Replico Medical Ab | Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov |
JPH03271233A (ja) * | 1990-03-19 | 1991-12-03 | Inst Pasteur | ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発 |
CA2047078A1 (en) * | 1990-07-19 | 1992-01-20 | Steven S. Bondy | Cyclic hiv principal neutralizing determinant peptides |
CA2047042A1 (en) * | 1990-07-19 | 1992-01-20 | John Hannah | Cyclic hiv principal neutralizing determinant peptides |
JPH05310785A (ja) * | 1991-09-30 | 1993-11-22 | Nitto Denko Corp | Hiv関連環状ペプチドおよびこれを固定化した吸着体 |
DE69333537T2 (de) * | 1992-03-27 | 2005-06-16 | Advanced Immuni T, Inc. | T-peptid und damit verwandte Peptide in der Behandlung von entzündungen einschlies slich der Multiplen Sklerose |
CA2952475C (en) | 2005-12-09 | 2022-08-09 | Vectus Biosystems Limited | Vip fragment for the treatment of myocardial fibrosis |
KR101215215B1 (ko) | 2008-09-02 | 2012-12-24 | 니혼도꾸슈도교 가부시키가이샤 | 스파크 플러그 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9328391B1 (en) * | 1984-08-22 | 2016-05-03 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Cloning and expression of HIV-1 DNA |
GB8501473D0 (en) * | 1985-01-21 | 1985-02-20 | Pasteur Institut | Cloned dna sequences |
DE122005000039I1 (de) * | 1984-10-18 | 2006-02-23 | Pasteur Institut | DNS-Fragmente des GAG-Gens von LAV |
CA1341423C (en) * | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
DE3650011T2 (de) * | 1985-04-08 | 1994-11-17 | Genetic Systems Corp | EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND. |
IE64785B1 (en) * | 1985-04-08 | 1995-09-06 | Genetic Systems Corp | Expression of immunologically reactive viral proteins |
DK171119B1 (da) * | 1985-04-19 | 1996-06-17 | Hoffmann La Roche | AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin |
ATE116006T1 (de) * | 1985-04-29 | 1995-01-15 | Genetic Systems Corp | Synthetische antigene zum nachweis von aids. |
GB8525615D0 (en) * | 1985-10-17 | 1985-11-20 | Hoffmann La Roche | Polypeptides |
WO1987002775A1 (en) * | 1985-10-24 | 1987-05-07 | Southwest Foundation For Biomedical Research | Synthetic peptides and use for diagnosis and vaccination for aids and arc |
JP2837669B2 (ja) * | 1985-11-07 | 1998-12-16 | プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ | T−細胞リンパ趨行性ウイルス蛋白及びその分析 |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
IE63109B1 (en) * | 1986-06-23 | 1995-03-22 | Genetic Systems Corp | Human monoclonal antibody to lymphadenopathy-associated virus |
EP0255190A3 (en) * | 1986-08-01 | 1990-08-29 | Repligen Corporation | Recombinant polypeptides and their uses, inclusing assay for aids virus |
JPH0762031B2 (ja) * | 1986-12-30 | 1995-07-05 | アメリカ合衆国 | エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド |
-
1987
- 1987-08-13 NZ NZ221440A patent/NZ221440A/xx unknown
- 1987-08-14 ZW ZW154/87A patent/ZW15487A1/xx unknown
- 1987-08-17 YU YU152587A patent/YU152587A/sh unknown
- 1987-08-17 FI FI873553A patent/FI873553A/fi not_active Application Discontinuation
- 1987-08-18 IL IL83580A patent/IL83580A/xx unknown
- 1987-08-18 ES ES8702431A patent/ES2010727A6/es not_active Expired
- 1987-08-19 IE IE221987A patent/IE60671B1/en not_active IP Right Cessation
- 1987-08-19 NO NO873495A patent/NO300462B1/no unknown
- 1987-08-19 GR GR871298A patent/GR871298B/el unknown
- 1987-08-19 DK DK433087A patent/DK433087A/da not_active Application Discontinuation
- 1987-08-19 SE SE8703225A patent/SE506025C2/sv not_active IP Right Cessation
- 1987-08-19 AU AU77201/87A patent/AU616156B2/en not_active Ceased
- 1987-08-19 HU HU873707A patent/HU214439B/hu not_active IP Right Cessation
- 1987-08-19 NL NL8701950A patent/NL8701950A/nl not_active Application Discontinuation
- 1987-08-19 IT IT21678/87A patent/IT1222518B/it active
- 1987-08-19 BE BE8700922A patent/BE1000811A4/fr not_active IP Right Cessation
- 1987-08-19 KR KR1019870009058A patent/KR920008744B1/ko not_active IP Right Cessation
- 1987-08-19 FR FR878711736A patent/FR2603107B1/fr not_active Expired - Fee Related
- 1987-08-19 DE DE19873727703 patent/DE3727703A1/de not_active Withdrawn
- 1987-08-19 LU LU86972A patent/LU86972A1/fr unknown
- 1987-08-19 GB GB8719587A patent/GB2196634B/en not_active Expired - Fee Related
- 1987-08-20 CH CH3210/87A patent/CH675728A5/de not_active IP Right Cessation
- 1987-08-20 AT AT0208987A patent/AT398080B/de not_active IP Right Cessation
- 1987-08-20 PT PT85567A patent/PT85567B/pt not_active IP Right Cessation
- 1987-08-20 PL PL1987267401A patent/PL155084B1/pl unknown
- 1987-08-20 JP JP62207336A patent/JPS6485928A/ja active Pending
- 1987-08-20 CS CS876136A patent/CS275838B6/cs unknown
- 1987-08-28 OA OA59183A patent/OA08652A/xx unknown
-
1993
- 1993-12-29 NO NO934897A patent/NO302176B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO882103D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
NO173213C (no) | Fremgangsmaate for fremstilling av et preparat omfattende et liposom | |
NO934897L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
NO885641D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk preparat. | |
NO880520D0 (no) | Fremgangsmaate for fremstilling av et cholestyraminpreparat | |
NO175286C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat som omfatter dobbeltveggede mikrokapsler | |
NO903264D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av mikropartikler. | |
NO173486C (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat for transdermal administrasjon av legemidler | |
FI894637A (fi) | Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi | |
NO871790D0 (no) | Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat. | |
NO170516C (no) | Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat | |
FI892640A (fi) | Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
NO892826L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer. | |
NO172447C (no) | Fremgangsmaate for fremstilling av b-avermectiner | |
NO883054L (no) | Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger. | |
NO884052D0 (no) | Fremgangsmaate for fremstilling av et terapeutisk preparat. | |
NO173590C (no) | Fremgangsmaate for fremstilling av et stabilt nikorandilholdig farmasoeytisk preparat | |
NO901232L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
NO870368L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig virkning. | |
NO177485C (no) | Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat | |
NO870866D0 (no) | Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat. | |
NO171792C (no) | Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer | |
NO171910C (no) | Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler | |
PT87672A (pt) | Process for preparing a pharmaceutical composition | |
NO173727C (no) | Fremgangsmaate for fremstilling av et preparat mot psoriasis |